Newsletters

02.16.18

Passive Investors in Payday Lending Operations Get Partial Reprieve

While tossing certain claims brought by Pennsylvania’s attorney general, a federal judge denied part of a motion to dismiss brought by online short-term lenders in an action accusing them of “renting” Native American tribes and out-of-state banks.


02.15.18

IAB Seeks to Influence Marketers, Publishers With Influencer Guidance

Need help with influencer marketing? The Interactive Advertising Bureau has published a new guide that publishers and marketers can use to maximize their influencer marketing programs.


02.15.18

The FTC’s Clean Slate

For the Federal Trade Commission (FTC), 2018 looks to be a year of transition, with President Donald J. Trump officially submitting four commissioner nominations for Senate approval.


02.15.18

Question Mark Leaves Court Questioning Defamation Claim

Demonstrating the power of punctuation, actor James Woods dodged a Twitter defamation suit after a federal court judge found that his use of a question mark meant his tweet was not a false statement of fact and merely invited the reader to reach his or her own conclusion.


02.15.18

NAD: Allergy Medication Too Smart for Its Own Good

Claims touting an allergy medication as “smart” or “wise” conferred a clinically meaningful benefit as compared to a competitor’s product and should be discontinued, the National Advertising Division (NAD) recently recommended.


02.12.18

Federal Transfer Tax Exemptions Increased … Temporarily

With the passage of the Tax Cuts and Jobs Act (Reconciliation Act of 2017) on December 19, 2017 (the Act), Congress provided increased, albeit temporary, relief to taxpayers who otherwise might be subject to federal transfer taxes (i.e., Estate, Gift and Generation-Skipping Transfer Taxes).


02.08.18

Supreme Court Hits Pause on State Statutes of Limitation

Weighing in on the definition of “tolled,” the Supreme Court declared the time limit on state claims stops while federal claims are pending.


02.08.18

FTC Keeps Its Hat On Over ‘Made in USA’ Claims

Tipping its hat to the Enforcement Policy Statement on U.S. Origin Claims, the Federal Trade Commission (FTC) filed suit against Bollman Hat Co. and a subsidiary for deceiving consumers with “Made in USA” claims for its hats and third-party products. 


02.08.18

FDA, FTC Try to Stop Opioid Cessation Products

Marketers of opioid cessation products received warning letters from the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC), cautioning them about unproven claims for the treatment of opioid addiction and withdrawal.


02.08.18

Nationwide Class Dismissed by Illinois Federal Court

Applying last year’s U.S. Supreme Court decision in Bristol-Myers Squibb Co. v. Superior Court of California, an Illinois federal court dismissed nationwide class claims against NBTY, Inc., for lack of jurisdiction.